Is the Options Market Predicting a Spike in TG Therapeutics Stock?

Core Viewpoint - Investors in TG Therapeutics, Inc. (TGTX) should closely monitor the stock due to significant movements in the options market, particularly the high implied volatility of the Jan 16, 2026 $3 Call option [1] Company Analysis - TG Therapeutics is currently rated as Zacks Rank 3 (Hold) within the Medical - Biomedical and Genetics industry, which ranks in the top 37% of the Zacks Industry Rank [3] - Over the last 60 days, the Zacks Consensus Estimate for the current quarter has decreased from 27 cents per share to 25 cents per share [3] Options Market Insights - The high implied volatility suggests that options traders are anticipating a significant price movement for TG Therapeutics shares, indicating potential upcoming events that could lead to a major rally or sell-off [2][4] - Options traders often seek high implied volatility options to sell premium, aiming to benefit from the decay of the option's value if the underlying stock does not move as much as expected [4]